Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Dermatology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Dermatology Other
    Converting to Sirolimus From Calcineurin Inhibitors Reduces Risk of Skin Cancer in Kidney Transplant Patients: Presented at Renal Week 2009 - (DGDispatch)
    Spinosad Better Than Permethrin for Pediculosis Capitis in Children: Presented at AAP - (DGDispatch)
    Topical Onychomycosis Treatment More Effective Than Oral Treatment : Presented at EADV - (DGDispatch)
    Mycophenolate Mofetil Benefits Patients With Pemphigus Vulgaris: Presented at EADV - (DGDispatch)
    Health Canada Approves Telavancin for Complicated Skin, Skin Structure Infections - (DGNews)

    News archive

     Recent webcasts/CME - Dermatology Other
      The Prevention and Treatment of Pressure Ulcers
      Contemporary Options for the Management of Scars
      Pediatric and Adolescent Sports-Related Injuries and Ailments
      The Wound Healing Process
      Current Concepts in Healing Chronic Diabetic Foot Ulcerations

      Webcasts/CME archive

       Recent cases - Dermatology Other
        Yellow Nail Syndrome
        Acquired Perforating Dermatosis: Association with Diabetes and Renal Failure
        Complete Remission of Severe Idiopathic Cold Urticaria on Interleukin-1 Receptor Antagonist (Anakinra)
        Ulcerative Leg Nodules in a Transplant Recipient
        Pearly Penile Papules

        Cases archive
          




        my personal edition > dermatology other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Bleomycin Successful In Treating Resistant Hand Warts

        A DGReview of :"Pulsed dye laser and intralesional bleomycin for treatment of resistant viol hand warts"
        Lasers in Surgery and Medicine

        03/20/2002
        By David Ball


        Resistant hand warts and warts found in difficult sites in immunosuppressed patients can be successfully treated by combining pulsed dye laser and intralesional bleomycin.

        Initial treatment with pulsed dye laser prepares the wart for the bleomycin injection and ensures it goes into the base of the wart to minimise the risk of infiltration of normal skin. This new technique for safely administrating bleomycin into warts was tested by two investigators at Leeds Laser Centre, Leeds General Infirmary, England.

        Their open study of ten patients with resistant viral hand warts of at least three years duration included four on long-term immunosuppressant drugs. A total of 18 warts were treated. Following anaesthesia with 1% lignocaine to the local area, warts were treated with a pulsed dye laser (7 mm spot, fluence 10 J/cm²). Bleomycin (0.5 IU/ml) was then injected into the base of the wart and subjects were followed-up with monthly treatment.

        All eight warts in the six immunocompetent subjects were successfully cleared, as were eight out of ten warts in the immunosuppressed patients. In total, all but two of the 18 warts, 89 percent, were cleared.

        While the remaining two warts partially responded to two treatments, no further therapy was given because the patient was happy with the result. There were no serious side effects in any of the subjects.

        The researchers point out that viral warts, some of which are resistant to multiple therapies particularly in immunosuppressed patients, affect 7 - 10 percent of the population and can be a major burden on dermatology departments.

        They found the combination of pulsed dye laser and intralesional bleomycin was safe, rapid and well tolerated but suggest a larger controlled study is needed to confirm these findings.
        Lasers Surg. Med. 30:135-140, 2002. "Pulsed dye laser and intralesional bleomycin for treatment of resistant viol hand warts"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send